Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRA Antikörper

Dieses Anti-HLA-DRA-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von HLA-DRA in FACS, IF und IHC (f). Geeignet für Human.
Produktnummer ABIN6937414

Kurzübersicht für HLA-DRA Antikörper (ABIN6937414)

Target

Alle HLA-DRA Antikörper anzeigen
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reaktivität

  • 119
  • 17
  • 11
  • 9
  • 9
  • 9
  • 9
  • 4
  • 3
  • 2
Human

Wirt

  • 73
  • 68
  • 4
  • 1
  • 1
Maus

Klonalität

  • 74
  • 73
Monoklonal

Konjugat

  • 88
  • 14
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Dieser HLA-DRA Antikörper ist unkonjugiert

Applikation

  • 74
  • 63
  • 51
  • 38
  • 33
  • 27
  • 22
  • 21
  • 9
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

19-26-1-same as MB-26-1
  • Spezifität

    This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Raji cells

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Raji, Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Andere Bezeichnung

    HLA-DRA

    Hintergrund

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA,HLA-DRA (MHC II)
    Cellular localisation: Cell surface

    Molekulargewicht

    36kDa (α, chain) and 27kDa (β, chain)

    Gen-ID

    3122, 520048

    UniProt

    P01903

    Pathways

    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!